About Torax Biosciences
Torax Biosciences is a company based in Newtownabbey (United Kingdom) founded in 2017 was acquired by EDX Medical Group in February 2023.. The company has 4 employees as of March 31, 2022. Torax Biosciences offers products and services including Clinical Chemistry Reagents, Blood Grouping Reagents, COVID-19 Testing Kits, Latex Serology, and Syphilis Assays. Torax Biosciences operates in a competitive market with competitors including GenMark Diagnostics, NeuMoDx, Kryptos Biotechnologies, Sense Biodetection and Altratech, among others.
- Headquarter Newtownabbey, United Kingdom
- Employees 4 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Torax Biosciences Limited
- Date of Incorporation 17 Jul, 2017
- Jurisdiction BELFAST, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
4
as on Mar 31, 2022
-
Acquired by
EDX Medical Group
(Feb 17, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Torax Biosciences
Torax Biosciences offers a comprehensive portfolio of products and services, including Clinical Chemistry Reagents, Blood Grouping Reagents, COVID-19 Testing Kits, Latex Serology, and Syphilis Assays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Reagents for clinical chemistry analysis in medical diagnostics
Reagents used for blood grouping and compatibility testing
Kits for detecting SARS-CoV-2 antigens in samples
Tests for detecting antibodies through latex agglutination
Assays for diagnosing syphilis infections
Funding Insights of Torax Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Torax Biosciences
Torax Biosciences has secured backing from 1 investor. Prominent investors backing the company include EDX Medical Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical diagnostics solutions are researched by the laboratory.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Torax Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Torax Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Torax Biosciences Comparisons
Competitors of Torax Biosciences
Torax Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenMark Diagnostics, NeuMoDx, Kryptos Biotechnologies, Sense Biodetection and Altratech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Developer of a platform for low cost molecular testing
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
|
| domain | founded_year | HQ Location |
Provider of point of care molecular diagnostics solutions
|
|
| domain | founded_year | HQ Location |
Next-generation molecular detection kits for viral diseases are developed.
|
|
| domain | founded_year | HQ Location |
Smartphone-based DNA detection platform is developed for diagnostics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Torax Biosciences
When was Torax Biosciences founded?
Torax Biosciences was founded in 2017.
Where is Torax Biosciences located?
Torax Biosciences is headquartered in Newtownabbey, United Kingdom. It is registered at Newtownabbey, Northern Ireland, United Kingdom.
Who is the current CEO of Torax Biosciences?
Lawrence McGrath is the current CEO of Torax Biosciences.
How many employees does Torax Biosciences have?
As of Mar 31, 2022, the latest employee count at Torax Biosciences is 4.
What does Torax Biosciences do?
Torax Biosciences was founded in 2017 and is based in Newtownabbey, United Kingdom. Operations focus on the development of in vitro diagnostic (IVD) reagents and instruments within the biotechnology sector. Point-of-care, genomic, and laboratory test solutions are provided for conditions including cancer, heart disease, neurology, and infectious diseases. Leadership is held by CEO Lawrence McGrath.
Who are the top competitors of Torax Biosciences?
Torax Biosciences's top competitors include GenMark Diagnostics, NeuMoDx and Altratech.
What products or services does Torax Biosciences offer?
Torax Biosciences offers Clinical Chemistry Reagents, Blood Grouping Reagents, COVID-19 Testing Kits, Latex Serology, and Syphilis Assays.
Who are Torax Biosciences's investors?
Torax Biosciences has 1 investor. Key investors include EDX Medical Group.